Oncology trial authors fail to declare conflicts of interest

Financial conflicts of interest are not being declared by the authors of oncology clinical drug trials published in in the major medical journals, US figures reveal. One in three authors of clinical trials used as a basis for FDA registration of oncology drugs did not declare financial payments from pharmaceutical sponsors, an analysis published in ...

Already a member?

Login to keep reading.

© 2022 the limbic